Bruker (BRKR) Cash from Financing Activities (2010 - 2026)

Bruker (BRKR) has reported Cash from Financing Activities for 17 consecutive years, with $149.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities rose 56.23% year-over-year to $149.2 million; the trailing twelve-month figure through Jun 2026 stood at $35.1 million (up 205.09% YoY), and the FY2025 full-year result was $135.1 million, down 89.01% from the prior year.
• Cash from Financing Activities improved to $149.2 million in Q2 2026 per BRKR's latest filing, from -$204.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $1.2 billion in Q2 2024 and bottomed at -$217.4 million in Q1 2022.
• Historically, Cash from Financing Activities has averaged $38.9 million across 5 years, with a median of -$43.6 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities slumped 3053.85% in 2022, then surged 11321.36% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$36.1 million in 2022, then sank by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then sank by 123.47% to -$167.6 million in 2025, then soared by 189.02% to $149.2 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $149.2 million, -$204.9 million, and -$167.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.